Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 26, 2019 Off

US Bioservices Selected by Janssen as Single-Source Specialty Pharmacy Provider for BALVERSA™ (erdafitinib)

By BusinessWire

FRISCO, Texas–(BUSINESS WIRE)–US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected…

April 26, 2019 Off

US Bioservices Selected by Janssen as Single-Source Specialty Pharmacy Provider for BALVERSA™ (erdafitinib)

By BusinessWire

FRISCO, Texas–(BUSINESS WIRE)–US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected…

April 26, 2019 Off

SparingVision to Present Preclinical Datas for Retinitis Pigmentaria’s Treatment during Annual Congress of the Association for Research in Vision and Ophthalmology (ARVO)

By BusinessWire

Vancouver, Canada, from April 28th to May 2nd, 2019 PARIS–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank"gt;#biotechlt;/agt;–SparingVision, a biotechnology company focused on the discovering…

April 26, 2019 Off

SparingVision to Present Preclinical Datas for Retinitis Pigmentaria’s Treatment during Annual Congress of the Association for Research in Vision and Ophthalmology (ARVO)

By BusinessWire

Vancouver, Canada, from April 28th to May 2nd, 2019 PARIS–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank"gt;#biotechlt;/agt;–SparingVision, a biotechnology company focused on the discovering…

April 26, 2019 Off

Global $3.28 Billion Probiotic Supplements Market (2018-2027): Development of Dry Probiotic Supplements for Chronic Diseases will Fuel Growth at an Expected CAGR of 10.15% During 2018-2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Probiotic Supplements Market (2018-2027)” report has been added to ResearchAndMarkets.com’s offering. The global probiotic supplements market is projected…

April 26, 2019 Off

Genexine and NeoImmuneTech Announce Dosing of First Patient in the Combination Trial of Hyleukin-7™ with Merck’s KEYTRUDA® in Triple-Negative Breast Cancer

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–Genexine, Inc. (Genexine) and NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the first patient…

April 26, 2019 Off

Genexine and NeoImmuneTech Announce Dosing of First Patient in the Combination Trial of Hyleukin-7™ with Merck’s KEYTRUDA® in Triple-Negative Breast Cancer

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–Genexine, Inc. (Genexine) and NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the first patient…

April 26, 2019 Off

Global Molecular Biology Enzymes, Kits, and Reagents Markets, 2018-2019 & 2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The molecular…

April 26, 2019 Off

BioTime to Present SCiStar Clinical Study Top-Line Data at the 26th Annual American Society for Neural Therapy and Repair Conference

By BusinessWire

ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing new…

April 26, 2019 Off

Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia

By BusinessWire

Submission to EMA follows Biologics Licensing Application submission to U.S. FDA earlier this month SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Celgene…

Posts pagination

Previous 1 … 3,248 3,249 3,250 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine